Published by Iain Gilbert on 1st September 2026
(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
URL: http://www.digitallook.com/dl/news/story/36180143/...